Discover diagnostic pathology’s fascinating realm in Current Concepts in Hematopathology 2022. Discover the skill of microscopic hematolymphoid disease evaluation with renowned professionals. Discover how to use several ancillary studies effectively. This extensive training will expand your knowledge and skills. Current Concepts in Hematopathology provide cutting-edge insights. Stay current on medical advances and CME. Explore many topics to improve your understanding of this dynamic field. Stay ahead in Hematopathology by joining us on this discovery trip.
Hematolymphoid proliferation morphologic interpretation and immunophenotyping: how to prevent typical mistakes. Find creative ways to handle cases beyond WHO diagnostic categories. Increase your diagnostic skills!
Discover how evidence-based guidelines, cutting-edge cytogenetics, and advanced molecular testing may transform diagnosis.
Discover Learning Objective Power:
Current Concepts in Hematopathology 2022 will empower and teach you vital skills to reach your greatest potential. Learn the key to success while you grow personally. Through this activity, participants will learn to:
- Utilize cost-effective supplementary studies to maximize diagnostic capability using morphologic criteria. Learn to diagnose many lymph node and bone marrow diseases.
- Discover how evidence-based criteria can accurately diagnose myeloid and lymphoid neoplasms.
- Diagnose the most difficult situations that defy classification.
- Understand hematolymphoid cancers and distinguish them from non-neoplastic mimics.
Find Your Ideal Audience of Current Concepts in Hematopathology 2022:
Pathology specialists, please! This course is customized for you. Get ready to elevate your practice with our skillfully developed curriculum.
TOPICS / SPEAKERS of Current Concepts in Hematopathology 2022:
- Nodal Small B-Cell Lymphomas –Â Elizabeth A. Morgan, MD
- Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma –Â Valentina Nardi, MD
- Question & Answer –Â Robert P. Hasserjian, MD – Moderator, Elizabeth A. Morgan, MD and Valentina Nardi, MD
- Immunodeficiency and Viral-Associated Lymphoproliferations –Â Judith A. Ferry, MD
- Updates in Cutaneous Lymphomas –Â Sam Sadigh, MD
- Question & Answer –Â Elizabeth A. Morgan, MD – Moderator, Judith A. Ferry, MD and Sam Sadigh, MD
- WHO Update – Follicular Lymphoma and Related Entities –Â Abner Louissaint Jr., MD, PhD
- Diffuse Large B-Cell Lymphoma Subtypes –Â Scott B. Lovitch, MD, PhD
- Question & Answer –Â Marian H. Harris, MD – Moderator, Abner Louissaint Jr, MD, PhD, and Scott B. Lovitch, MD, PhD
- Burkitt Lymphoma and High-Grade B-Cell Lymphomas – A Practical Guide and Update – Aliyah R. Sohani, MD
- Reactive Lymphadenopathies and Castleman Disease –Â Yasodha Natkunam, MD, PhD
- Question & Answer –Â Robert P. Hasserjian, MD – Moderator, Yasodha Natkunam, MD, PhD and Aliyah R. Sohani, MD
- Approach to Peripheral Smear Review –Â Elizabeth Courville, MD
- Myelodysplastic Syndrome and Its Differential Diagnosis –Â Robert P. Hasserjian, MD
- Question & Answer –Â Elizabeth A. Morgan, MD – Moderator, Elizabeth Courville, MD, and Robert P. Hasserjian, MD
- Acute Myeloid Leukemia and Acute Leukemias of Ambiguous Lineage –Â Olga K. Weinberg, MD
- Acute Lymphoblastic Leukemia –Â Marian H. Harris, MD, PhD
- Question & Answer –Â Robert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD, and Olga K. Weinberg, MD
- Eosinophilia and Mastocytosis –Â Olga Pozdnyakova, MD, PhD
- Myelodysplastic/Myeloproliferative Neoplasms –Â Robert P. Hasserjian, MD
- Question & Answer –Â Marian H. Harris, MD, PhD – Moderator, Robert P. Hasserjian, MD and Olga Pozdnyakova, MD, PhD
- Interpreting Flow Cytometry Minimal Residual Disease in Acute Leukemia –Â Sa A. Wang, MD
- Practical Interpretation of Molecular Testing in Myeloid Neoplasms –Â Annette S. Kim, MD, PhD
- Question & Answer –Â Elizabeth A. Morgan, MD – Moderator, Annette S. Kim, MD, PhD, and Sa A. Wang, MD
- Challenges in the Diagnosis of Hodgkin Lymphomas –Â Marian H. Harris, MD, PhD
- Primary Mediastinal Large B-Cell and Grey-Zone Lymphomas –Â Scott J. Rodig, MD, PhD
- Question & Answer –Â Robert P. Hasserjian, MD – Moderator, Marian H. Harris, MD, PhD, and Scott J. Rodig, MD, PhD
- Indolent T-Cell Disorders –Â Kathleen H. Burns, MD, PhD
- Nodal T-Cell Lymphomas –Â Roberto Chiarle, MD
- Question & Answer –Â Marian H. Harris, MD, PhD – Moderator, Kathleen H. Burns, MD, PhD and Roberto Chiarle, MD
- Histiocytic and Dendritic Cell Neoplasms –Â Elizabeth A. Morgan, MD
- IgG4-Related Disease and Lymphadenopathy –Â Jacob R. Bledsoe, MD
- Blastic Plasmacytoid Dendritic Cell Neoplasm –Â Gabriel K. Griffin, MD
- Question & Answer –Â Marian H. Harris, MD, PhD – Moderator, Jacob R. Bledsoe, MD, Gabriel K. Griffin, MD and Elizabeth A. Morgan, MD
- Inherited Predisposition to Myeloid (and Hematological) Malignancies –Â Mark D. Fleming, MD, DPhil
- Spleen Pathology –Â Lawrence R. Zukerberg, MD
- Question & Answer –Â Elizabeth A. Morgan, MD – Moderator, Mark D. Fleming, MD, DPhil and Lawrence R. Zukerberg, MD
See Also: USCAP Challenges In Hematopathology 2022 (Videos+PDFs)
Reviews
There are no reviews yet.